期刊文献+

铬结合物在铬中毒性肝损害中的作用 被引量:3

Study on the role of chromiumbinding substances in chromiuminduced hepatic damage
原文传递
导出
摘要 目的了解各种铬结合物与肝损害的关系。方法在铬中毒性肝损害的大鼠模型中,采用SephadexG50凝胶层析技术,对肝中铬结合物进行分离和测定。结果铬染毒大鼠肝组织中,除可检出高分子铬结合物(HMWCr,相对分子质量(MW)70000~12500)及低分子铬结合物(LMWCr,MW12500~500)外,还发现对照组未检出的小分子铬结合物(MMWCr,MW<500)。随染毒时间延长,肝损害加重,三者肝中分布变化明显:HMWCr由22.2%增至37.0%;MMWCr由2.2%增至5.0%;LMWCr则从75.6%降至58.0%。结论LMWCr可能与铬的解毒有关;MMWCr的出现并增多反映了机体形成LMWCr能力的紧张;MMWCr可能是攻击靶器官的主要活性因素。 Objective To study the role of chromiumbinding substances in chromiuminduced hepatic damage. Methods A subacute chromium intoxicated rat model was made and chromiumbinding substances in liver were isolated and measured by sephadex G50 column chromatography and UVAAS. Results Only a high molecular weight chromiumbinding substance (HMWCr,MW700 00012 500) and a low molecular weight chromiumbinding substance (LMWCr,MW12 500500) could be detected in normal animals.But in chromiumexposed animals,a new minimal molecular weight chromiumbinding substance (MMWCr,MW<500) was found in addition to the above constituents.As the exposure time prolonged,hepatic damage aggravated and the distribution of three Crbinding substances was as follows:HMWCr from 22.2% to37.0%,MMWCr from 2.2% to 5.0%,LMWCr from 75.6% to 58.0%. Conclusion LMWCr play a main role in chromium detoxification.The appearance and increase of MMWCr reflected on the insufficiency of LMWCr formation.The MMWCr should be a major active factor on pathogenesis of Crintoxication.
出处 《中华劳动卫生职业病杂志》 CAS CSCD 1999年第3期164-167,共4页 Chinese Journal of Industrial Hygiene and Occupational Diseases
基金 国家自然科学基金
关键词 铬中毒性 肝损害 铬结合物 Hepatotoxic damage by chromiumChromiumbinding substances
  • 相关文献

参考文献2

  • 1王同明,生物化学及检验技术,1985年,336页
  • 2吴执中,职业病,1984年,145页

同被引文献31

  • 1张文新,张华磊.铬盐生产对工人健康危害的调查[J].工业卫生与职业病,2004,30(4):232-233. 被引量:9
  • 2张振中,刘利娥,刘洁,崔景彬,余波,黄全勇.谷胱甘肽-S转移酶的测定及其应用[J].河南医科大学学报,1995,30(4):419-421. 被引量:3
  • 3闫蕾,贾光.职业接触铬盐生物标志物的研究进展[J].中华预防医学杂志,2006,40(6):441-443. 被引量:17
  • 4国际铬业发展协会.铬的健康、安全和环境指导纲要.4版[EB/OL].(2007-01-31)[2008-12-17].http://www.Icdachromittm.com/pdf/publieations/FinalChineseGuidelines.pdf.
  • 5Costa M, Klein CB. Toxicty and careinogenicity of chromium compounds in humans(Review)[J]. Crit Rev Toxicol, 2006, 36:155-163.
  • 6刘信荣 孙文献 郑德成 等.腺苷脱氨酶活力测定方法探讨.中华医学检验杂志,1998,11(5):266-268.
  • 7Costa M. Potential hazards of hexavalent chromate in our drinking water (Review)[J]. Toxicol Appl Phamacol, 2003, 188: 1-5.
  • 8高泽宣,杜理国,王翔朴,安飞云,王安,王夷平.原子吸收法分析肾脏亚细胞组分中的镉[J].中华预防医学杂志,1997,31(2):127-128. 被引量:2
  • 9Ymmgueh S, Sano K, Shimojo N, et al. On the biological halftime of hexavalent Chromium in Rat' s [ J ]. Indust Health, 1983, 21 : 24 -27.
  • 10Wada O, Wu CY, Yanamoto A, et al. Purification and chromiumexeretory function of low - molecular- weight, chromium- binding substance for dog liver[ J ]. Envirion Res, 1983,32:228 - 229.

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部